Nano Dimension (NNDM) AGM 2024 Presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2024 Presentation summary
26 Jan, 2026Strategic transformation and value creation
Achieved significant scale through disciplined M&A, including acquisitions of Desktop Metal and Markforged, with expected combined revenue of $340M and $475M in cash at closing to support growth.
Delivered 29% organic revenue growth (FY23 vs. FY22), 1300 bps gross margin improvement, and 69% reduction in cash burn (H1'24 vs. H1'23).
Outperformed industry peers in share price performance over 1-, 3-, and 5-year periods, and since CEO Stern’s appointment.
Flexible capital allocation with over $160M in share buybacks since August 2022 and nearly $1.5B raised from 2020-2021.
Clear path to EBITDA positivity by Q4 2026, driven by operational efficiencies and synergy realization from acquisitions.
Board leadership and governance
Board consists of eight highly qualified directors, seven of whom are independent, with diverse skills aligned to growth strategy.
Enhanced governance includes separation of Chairman and CEO roles, board size reduction, and ongoing refreshment with three new directors since 2022.
Directors targeted by activist Murchinson, including CEO Yoav Stern and General Michael X. Garrett, are deemed critical for strategic oversight.
CEO compensation is closely tied to performance, with ~90% of annual target compensation linked to stock price and financial metrics.
Board’s expertise spans public company leadership, industrial technology, M&A, and financial stewardship.
Murchinson’s proposals and company response
Murchinson criticized for lacking a value creation plan, relevant director nominees, and understanding of the business.
Proposals from Murchinson aim to restrict M&A activity and remove key directors, which management claims would paralyze strategy and risk long-term value.
Murchinson’s nominees are described as unqualified, lacking additive manufacturing experience, and having questionable track records.
Management asserts that Murchinson’s agenda is to liquidate the company for short-term gain at the expense of other shareholders.
Shareholders are urged to vote in favor of management’s proposals to protect long-term value and ongoing transformation.
Latest events from Nano Dimension
- Board supports strategic review and declassification, opposes governance and director changes.NNDM
Proxy filing25 Jun 2026 - Proxy contest aims to declassify the board, restrict poison pills, and replace key directors.NNDM
Proxy filing18 Jun 2026 - Proposed merger with Infinite Epigenetics offers a 20% premium and pivots to AI-powered diagnostics.NNDM
Proxy filing17 Jun 2026 - $890M merger forms a Nasdaq-listed AI diagnostics leader targeting the $90–94B U.S. market.NNDM
M&A announcement16 Jun 2026 - Nano and Infinite plan a merger to create an AI-powered health diagnostics company, pending approvals.NNDM
Proxy filing15 Jun 2026 - Board supports declassification but opposes director removal and other governance changes.NNDM
Proxy filing11 Jun 2026 - Shareholders will vote on strategic direction, board structure, and director changes amid a proxy contest.NNDM
Proxy filing5 Jun 2026 - Strategic plan advances with cost cuts, asset sales, and a pivotal shareholder vote ahead.NNDM
Proxy filing5 Jun 2026 - Board opposes activist director replacements, prioritizing strategic review and shareholder value.NNDM
Proxy filing26 May 2026 - Q1 2026 revenue surged 106% year-over-year, but net loss deepened amid restructuring and impairment.NNDM
Q1 20267 May 2026